These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy]. Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667 [No Abstract] [Full Text] [Related]
6. Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis. Janssen S; van Rijswijk MH; Piers DA; de Jong GM Eur J Nucl Med; 1984; 9(12):538-41. PubMed ID: 6441712 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography. Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams D; Desgrez A; Blondeau M Am J Cardiol; 1993 Oct; 72(11):854-7. PubMed ID: 8213531 [No Abstract] [Full Text] [Related]
8. Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis--a case report. Low YH; Ang ES; Goh AS; Sundram FX; Sin FL Ann Acad Med Singap; 1995 Nov; 24(6):898-901. PubMed ID: 8839006 [TBL] [Abstract][Full Text] [Related]
10. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy. Ptacin MJ; Bamrah V; Duthie E Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368 [No Abstract] [Full Text] [Related]
11. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Gertz MA; Brown ML; Hauser MF; Kyle RA Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031 [TBL] [Abstract][Full Text] [Related]
12. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis]. Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892 [TBL] [Abstract][Full Text] [Related]
13. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870 [TBL] [Abstract][Full Text] [Related]
14. Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report. Vanek JA; Cook SA; Bukowski RM J Nucl Med; 1977 Nov; 18(11):1086-8. PubMed ID: 72083 [No Abstract] [Full Text] [Related]
15. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis. Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666 [TBL] [Abstract][Full Text] [Related]
16. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810 [TBL] [Abstract][Full Text] [Related]
17. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102 [TBL] [Abstract][Full Text] [Related]